Completed NA INTERVENTIONAL 1-arm NCT01283126

Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery

Sponsor: Abbott Diabetes Care

Interventions euglycemic and hypoglycemic clamp

Updated 7 times since 2017 Last updated: May 4, 2017 Started: Jan 31, 2011 Primary completion: Oct 31, 2014 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01283126, this NA trial focuses on Hypoglycemia and remains completed. Sponsored by Abbott Diabetes Care, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jul 2017 — Jun 2018 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Feb 2017 — Jul 2017 [monthly]

Unknown Status NA
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Diabetes Care
Joslin Diabetes Center

Data source: Joslin Diabetes Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States